More articles from 5.1 Airway Pharmacology and Treatment

Consumption of asthma and allergy drugs in Finland
Paula Kauppi, Juha Jantunen, Jaana Martikainen, Mika Mäkelä, Tari Haahtela

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4119; DOI: 10.1183/13993003.congress-2016.PA4119
The use of a new intra-pulmonary percussive ventilation (IPPV) device to aid lung volume recruitment (LVR) and secretion clearance in a patient with C1 spinal cord injury (SCI)
Liam Campbell, Alison Armstrong

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4071; DOI: 10.1183/13993003.congress-2016.PA4071
Vitamin D for the management of asthma: Cochrane systematic review and meta-analysis
Adrian R. Martineau, Christopher J. Cates, Mitsuyoshi Urashima, Megan Jensen, Alex P. Griffiths, Ulugbek Nurmatov, Aziz Sheikh, Christopher J. Griffiths

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4112; DOI: 10.1183/13993003.congress-2016.PA4112
Inhaled roflumilast and tadalafil supress airway reactivity and inflammation in ovalbumin-sensitized guinea pigs
Juraj Mokry, Anna Urbanova, Martin Kertys, Ivana Medvedova, Peter Mikolka, Petra Kosutova, Daniela Mokra

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4092; DOI: 10.1183/13993003.congress-2016.PA4092
Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases
Hiroaki Kume, Osamu Nishiyama, Yuji Higashimoto, Yuji Tohda

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4050; DOI: 10.1183/13993003.congress-2016.PA4050
RPL554, an inhaled PDE3/4 inhibitor, causes profound and sustained bronchodilation in healthy volunteers and COPD patients
Dave Singh, Kathy Banner, Kenneth Newman

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4052; DOI: 10.1183/13993003.congress-2016.PA4052
Fluticasone propionate/formoterol breath-triggered inhaler: Ease-of-use and patient preference
David Bell, Lucielle Mansfield, Mark Lomax

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4109; DOI: 10.1183/13993003.congress-2016.PA4109
A weight-based exacerbation dose-response analysis of mepolizumab in severe asthma with eosinophilic phenotype
Isabelle Pouliquen, Daren Austin, Necdet Gunsoy, Steven Yancey

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4106; DOI: 10.1183/13993003.congress-2016.PA4106
MUC1-CT mediates corticosteroid responses in COPD
Lucia Diaz, Javier Milara, Esteban Morcillo, Adela Serrano, Ricardo Guijarro, Celia Sanz, Julio Cortijo

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4095; DOI: 10.1183/13993003.congress-2016.PA4095
Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study
Emanuel Citgez, Job van der Palen, Paul van der Valk, Kirsten Koehorst-ter Huurne, Kris Movig, Marjolein Brusse-Keizer

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4066; DOI: 10.1183/13993003.congress-2016.PA4066

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages

Contact us